Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients

被引:13
作者
Gordon, B
Lyden, E
Lynch, J
Tarantolo, S
Pavletic, Z
Bishop, M
Reed, E
Kessinger, A
Haire, W
机构
[1] Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Prevent Soc Med, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA
关键词
CNS dysfunction; multiple organ dysfunction; stem cell transplant;
D O I
10.1038/sj.bmt.1702082
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Development of CNS dysfunction in the setting of hematopoietic stem cell transplant (HSCT) has been previously shown to predict for subsequent second organ dysfunction and death. In this paper, we describe the characteristics of this isolated CNS dysfunction, and its relationship to multiple organ dysfunction syndrome (MODS) after HSCT, Twenty-one of 186 patients undergoing HSCT developed CNS dysfunction as their first organ dysfunction a mean of 22.8 +/- 0.9 days after the start of the preparative regimen. Compared with 137 patients who developed no organ dysfunction, patients presenting with CNS dysfunction were more likely to have undergone allogeneic HSCT (P = 0.001) and to have received a total body irradiation-based regimen (P = 0.001), and were less likely to have been transplanted for lymphoma (P = 0.008). Patients who developed CNS dysfunction were more likely to die than those with no organ dysfunction (P < 0.001). Of the 21 patients who developed CNS dysfunction, 48% resolved their dysfunction by a mean of 4.6 days later without progression to second organ dysfunction, and 90% of these patients survived to day 100, Fifty-two percent of patients with CNS dysfunction progressed to second organ dysfunction (pulmonary or hepatic) a mean of 5.5 days later, and only 36% survived to day 100 (P = 0.02). The patients who progressed to second organ dysfunction and those who did not were not different in terms of type of HSCT (allogeneic vs autologous), stem cell source (blood vs bone marrow), age, diagnosis or preparative regimen. Development of CNS dysfunction in the setting of HSCT, as with other organ dysfunctions (such as hepatic veno-occlusive disease), probably represents an early manifestation of a systemic disorder predisposing for MODS, increasing the risk of transplant-related mortality. Early systemic therapies directed at modulating this systemic disorder are probably indicated.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 25 条
  • [1] LIMITS OF THE MINI-MENTAL STATE AS A SCREENING-TEST FOR DEMENTIA AND DELIRIUM AMONG HOSPITAL PATIENTS
    ANTHONY, JC
    LERESCHE, L
    NIAZ, U
    VONKORFF, MR
    FOLSTEIN, MF
    [J]. PSYCHOLOGICAL MEDICINE, 1982, 12 (02) : 397 - 408
  • [2] Early neurologic complications following allogeneic bone marrow transplant for leukemia - A prospective study
    Antonini, G
    Ceschin, V
    Morino, S
    Fiorelli, M
    Gragnani, F
    Mengarelli, A
    Iori, AP
    Arcese, W
    [J]. NEUROLOGY, 1998, 50 (05) : 1441 - 1445
  • [3] Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)
    Bone, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) : 680 - 687
  • [4] DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98
  • [5] FAIONI EM, 1993, BLOOD, V81, P3458
  • [6] FAIST FN, 1983, J TRAUMA, V9, P775
  • [7] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [8] FURLONG TG, 1994, CANCER NURS, V17, P27
  • [9] Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation
    Gordon, B
    Tarantolo, S
    Ruby, E
    Stephens, L
    Lynch, J
    Kessinger, A
    Haire, W
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (10) : 999 - 1003
  • [10] GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109